European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

8 EU fundings (€0.00): Rheuma Tolerance for Cure … Bdl Year 2017 EU Research and Innovation programme "Horizon"

Text

Companies House 00835139

01/01/2017 EU funding (€12M): Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106
01/02/2017 EU funding (€3,549,833): Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055
01/09/2017 EU funding (€6,000,000): Rheuma Tolerance for Cure
01/01/2017 EU funding (€8,000,000): Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Glaxosmithkline Research & Development Ltd., London.

Printing is only available to North Data premium service subscribers.